Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 33,293 | 34,752 | 39,675 | 46,311 | 52,507 |
| Cost of Goods | 6,592 | 4,048 | 3,790 | 4,561 | 3,902 |
| Gross Profit | 26,701 | 30,704 | 35,885 | 41,750 | 48,605 |
| Operating Expenses | 39,918 | 34,832 | 10,557 | 8,185 | 16,166 |
| Operating Income | -12,625 | -4,080 | 26,118 | 34,126 | 33,341 |
| Interest Expense | 1,597 | 263 | 263 | 263 | 263 |
| Other Income | -341 | -1,343 | 1,745 | 2,434 | 1,371 |
| Pre-tax Income | -14,563 | -5,686 | 27,600 | 36,297 | 34,449 |
| Income Tax | -2,327 | 2,559 | 5,921 | 7,370 | 8,539 |
| Net Income Continuous | -12,236 | -8,245 | 21,679 | 28,927 | 25,910 |
| Net Income | $-12,236 | $-8,245 | $21,679 | $28,927 | $25,910 |
| EPS Basic Total Ops | -0.32 | -0.18 | 0.54 | 0.70 | 0.63 |
| EPS Basic Continuous Ops | -0.32 | -0.18 | 0.54 | 0.70 | 0.63 |
| EPS Diluted Total Ops | -0.32 | -0.18 | 0.52 | 0.68 | 0.61 |
| EPS Diluted Continuous Ops | -0.32 | -0.18 | 0.52 | 0.68 | 0.61 |
| EBITDA(a) | $-10,122 | $-1,129 | $27,171 | $34,900 | $34,178 |